Aesica has pushed ahead with the next stage in its technical and innovation strategy with the appointment of a Global Technical Director, Bashir Hansraj, responsible for developing lead technical centres across the entire international Aesica network from API and drug product development sites right through to finished product manufacturing and packaging.
Based at Aesica headquarters in Newcastle (UK), Hansraj will lead and direct the company’s global technical and innovation strategy across the full spectrum of API and dosage form development.
Technical centres will be dedicated to specific dosage forms including; oral solids, oral liquids, topicals, inhalation and parenterals.
With over 30-years’ experience in the pharmaceutical industry and having held senior management R&D positions - within Pfizer Consumer Healthcare, J&J, Pfizer Global R&D and most recently at Catalent where he was head of Research and Development - Hansraj brings a depth of technical expertise and business acumen in new product development and technology transfer for pre-proof of concept to post launch assets on a global scale.
In addition to Life Science degrees he also has an MBA and, in his previous roles, led the development and commercialization of many leading OTC and Rx brands utilizing many technology platforms.